Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Natural Alternat.

Start price
Target price
Perf. (%)
€7.95
22.04.23
-
22.04.24
-27.04%
23.04.24

StockNews.com 
22.04.23 50%
buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€14.50
22.04.23
-
22.04.24
17.24%
23.04.24

StockNews.com 
22.04.23 50%
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.38
20.04.23
-
20.04.24
-9.98%
21.04.24

Robert W. Baird 
20.04.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.40
20.04.23
-
20.04.24
205.00%
21.04.24

Robert W. Baird 
20.04.23 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.67
20.04.23
€9.11
20.04.24
-38.50%
21.04.24

Evercore ISI 
20.04.23 50%
buy
Innoviva Inc.

Start price
Target price
Perf. (%)
€10.70
20.04.23
€20.50
20.04.24
29.91%
21.04.24

EF Hutton Acquisition Co. I 
20.04.23 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.67
20.04.23
€12.77
20.04.24
-38.50%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€41.00
20.04.23
€54.71
20.04.24
-40.98%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€2.73
20.04.23
€16.39
20.04.24
39.05%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
20.04.23
€14.57
20.04.24
-69.78%
21.04.24

HC Wainwright 
20.04.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€56.40
20.04.23
€60.11
20.04.24
22.34%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€81.50
17.04.23
-
17.04.24
94.17%
18.04.24

Stifel Nicolaus 
17.04.23 50%
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€18.96
17.04.23
€25.65
17.04.24
-29.79%
18.04.24

HC Wainwright 
17.04.23 50%
sell
Avinger Inc.

Start price
Target price
Perf. (%)
€0.60
16.04.23
-
16.04.24
-43.19%
17.04.24

StockNews.com 
16.04.23 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.11
02.04.24
-
02.04.25
-38.74%
16.04.24

Could be very worthwhile Investment >20% year
thomasw 
02.04.24 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.82
15.04.23
-
15.04.24
-58.81%
16.04.24

StockNews.com 
15.04.23 50%
buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.75
15.04.24
€3.00
31.10.25
-
15.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 60%
buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.43
24.06.23
€3.00
31.12.25
-43.01%
15.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 60%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€66.50
07.04.24
-
07.04.25
0.75%
14.04.24

Could be very worthwhile Investment >20% year
Vassago1 
07.04.24 50%
buy
Axonics Modulation Technologies Inc

Start price
Target price
Perf. (%)
€50.50
13.04.23
-
13.04.24
23.76%
14.04.24

Mizuho 
13.04.23 50%
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€33.50
13.04.23
€59.72
13.04.24
-29.85%
14.04.24

Canaccord Genuity Group Inc. 
13.04.23 50%
sell
AnaptysBio Inc

Start price
Target price
Perf. (%)
€19.70
13.04.23
€28.05
13.04.24
1.02%
14.04.24

JPMorgan Chase & Co. 
13.04.23 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.14
02.04.24
-
02.04.25
-28.14%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.60
02.04.24
-
02.04.25
-48.88%
13.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
02.04.24 0%
buy
Alpine Immune Sciences Inc

Start price
Target price
Perf. (%)
€11.50
22.07.23
€15.00
31.08.26
430.43%
12.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
22.07.23 50%